Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
Part of paid clinical trials in Miami, Florida.
- Sponsor
- Scientific Institute San Raffaele
- Study ID
- NCT06626243
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy. There are no risks for the patients, as this is a retrospective data collection.
Key Dates
- Start date
- Sep 30, 2024
- Status verified
- Nov 2024
- Primary completion
- Feb 15, 2025
- Completion
- Oct 15, 2025
Study Design
- Enrollment
- 140 participants (estimated)
Arms
- Arm: Robotic ApproachAdult patients diagnosed with locally advanced and resectable non-small cell lung cancer (NSCLC) who underwent robotic lung resection
- Arm: video-assisted thoracoscopic surgery (VATS) ApproachAdult patients diagnosed with locally advanced and resectable non-small cell lung cancer (NSCLC) who underwent video-assisted thoracoscopic surgery (VATS) lung resection
- Arm: Open ApproachAdult patients diagnosed with locally advanced and resectable non-small cell lung cancer (NSCLC) who underwent open lung resection
Primary Outcome Measure
The perioperative complication of video-assisted thoracoscopic surgery (VATS) approach [ Time Frame: 30-90 days after surgery ]
Central Contacts
- Pierluigi Novellis, Medical Doctor0226437202
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Baptist Health South Florida | Miami | Florida | 33176 | Mark R. Dylewski, MD |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Bernard J. Park, MD |
| West Virginia University | Morgantown | West Virginia | 26506 | Alper Toker, MD |
Find similar trials in Miami, FL
By condition
By specialty
Related Studies
- Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL ActivityPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung CancerPHASE3 · Recruiting · University of Texas Southwestern Medical Center · La Jolla, California
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California
- Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2PHASE1 · Recruiting · University of Rochester · Rochester, New York